Other potential applications of PSMA-PET/CT currently under investigation include identification of the suspected primary site of PCa, primary staging of intermediate-to-high risk PCa, and targeted biopsy [42,43,44,45]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.